For families facing the agonizing uncertainty of a rare disease diagnosis, time is often a critical factor. What can capture years of specialist visits, countless tests, and emotional strain is now being dramatically shortened thanks to the increasing adoption of whole genome sequencing (WGS) in routine clinical care. A recent study, published in Genome Medicine, highlights the success of a collaborative model at Karolinska University Hospital in Sweden, where WGS has led to genetic diagnoses for 23% of over 15,000 patients with suspected rare conditions.
Rare diseases, defined as those affecting a small percentage of the population – typically fewer than 1 in 2,000 people – are often complex and difficult to diagnose. The National Organization for Rare Disorders (NORD) estimates that there are over 7,000 rare diseases, impacting approximately 30 million Americans. NORD provides advocacy and resources for individuals and families affected by these conditions. Traditionally, diagnosis has relied on a step-by-step process of exclusion, analyzing only specific parts of the genome. This can be a lengthy and frustrating process, leaving patients and families in limbo.
A More Complete Genetic Picture
Whole genome sequencing differs significantly from these targeted tests. It involves analyzing the *entire* human genome – all approximately 3 billion base pairs of DNA – providing a far more comprehensive picture of a patient’s genetic makeup. The study at Karolinska University Hospital demonstrates that this broader approach can uncover genetic variations that would otherwise remain undetected. Researchers identified a genetic cause of disease in 3,538 individuals, revealing variants in over 1,500 different genes. This underscores the sheer diversity and complexity inherent in rare diseases.
“For many patients with suspected rare diseases, receiving a genetic diagnosis is highly significant,” explains Anna Lindstrand, adjunct professor at the Department of Molecular Medicine and Surgery, Karolinska Institutet, and senior consultant and head of section at Clinical Genetics and Genomics, Karolinska University Hospital. “It can provide an explanation for their condition and help guide treatment, follow‑up, and family planning. Whole genome sequencing allows us to detect genetic changes that would otherwise remain unnoticed.” The ability to pinpoint the genetic root of a condition isn’t just about knowing *what* is wrong; it’s about opening doors to more informed medical care.
From Research to Routine Care: A Collaborative Model
The success at Karolinska University Hospital wasn’t immediate. Over the past decade, the hospital and SciLifeLab – a national center for molecular biosciences in Sweden – deliberately built a system integrating WGS into the diagnostic pathway. This required close collaboration between clinical specialists, geneticists, bioinformaticians (scientists who analyze biological data), and laboratory staff. The key, researchers say, was establishing coordinated and well-defined processes that allowed for analyses tailored to each patient’s unique clinical presentation, with rapid translation of results into individualized care.
Anna Wedell, Professor at the Department of Molecular Medicine and Surgery, Senior Consultant at Karolinska University Hospital, and Director of Precision Medicine Center Karolinska, emphasizes the importance of this integrated approach. “By bringing together clinical medicine and advanced genomics, we have established a joint approach. I notice this as part of a broader shift in the healthcare system towards more precise and personalised care in Sweden, and the model could form an important foundation for that development.” This shift towards precision medicine – tailoring medical treatment to the individual characteristics of each patient – is gaining momentum globally.
The impact of this approach extends beyond simply identifying the cause of a disease. In some cases, a diagnosis has directly led to targeted treatment, particularly in congenital metabolic disorders and severe epilepsies. “In several cases, for example, in congenital metabolic disorders and severe epilepsies, we have been able to offer targeted treatment as a direct result of the diagnosis, preventing severe disease or early death,” Wedell stated.
Who Benefits Most?
The study found that a significant proportion of those who received a diagnosis through WGS were children. The researchers believe that the majority would not have received a diagnosis without this new multidisciplinary approach. This highlights the particular benefit for young patients, where early diagnosis and intervention can be crucial for development and long-term health outcomes. The diagnostic odyssey for children with rare diseases can be especially challenging, often involving multiple specialists and prolonged uncertainty. The National Human Genome Research Institute provides further information on the challenges and advancements in rare disease research.
The model developed at Karolinska University Hospital isn’t without its challenges. Analyzing the vast amount of data generated by whole genome sequencing requires significant computational resources and expertise. Interpreting the results and determining the clinical significance of genetic variants can be complex, requiring ongoing research and refinement of analytical tools. Ethical considerations surrounding genomic data privacy and potential discrimination also remain important areas of focus.
Looking ahead, the researchers are focused on expanding access to WGS and refining the diagnostic pipeline. They are also exploring the potential of using WGS data to identify new therapeutic targets and develop personalized treatment strategies. The next step involves further validation of the model in diverse populations and integration with other emerging technologies in genomic medicine.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the increasing role of genomic sequencing in healthcare? Share your comments below, and please share this article with anyone who might uncover it helpful.
